Efficacy of Dry Needling in Plantar Fasciitis

NCT02467465 | Completed Results DMC

• 1 other identifier: Univ. Complutense de Madrid
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

The plantar fasciitis (PF) is the most common cause of pain on the underside of the heel. About 10% to 20% of the population suffer once during their lifetime. PF concept began to describe at the end of XX century through the discovery of new clinical and histopathological signs of the plantar fascia. The difficulty of diagnosis, understanding and treatment of PF require us to develop new treatment avenues to improve the approach and the understanding of it. Dry needling (DN) as a treatment of myofascial pain syndrome (MPS) and myofascial trigger points (MTP) of muscle associated with the pathology, it may be a good treatment strategy, as demonstrated in the treatment of MPS in other body regions such as the neck, shoulder or the lumbar spine.

Conditions

Fasciitis, Plantar

Keywords

Fasciosis plantar; physiotherapy; fascitis plantar; dry needling

Outcome Measures

Primary Outcomes (4)

• Ultrasonographic Evaluation of the Thickness of the Affected Plantar Fascia, in Longitudinal View.

  Plantar fascia thickness in millimeters with ultrasonography at 0,5 centimeters from the calcaneo bone. Mean of 3 measures was taken.

  1 day.

• Ultrasonographic Evaluation of the Thickness of the Affected Plantar Fascia, in Longitudinal View.

  Plantar fascia thickness in millimeters with ultrasonography at 0,5 centimeters from the calcaneo bone. Mean of 3 measures was taken.

  1 month

• Ultrasonographic Evaluation of the Thickness of the Affected Plantar Fascia, in Longitudinal View.

  Plantar fascia thickness in millimeters with ultrasonography at 0,5 centimeters from the calcaneo bone. Mean of 3 measures was taken.

  3 month

• Ultrasonographic Evaluation of the Thickness of the Affected Plantar Fascia, in Longitudinal View.

  Plantar fascia thickness in millimeters with ultrasonography at 0,5 centimeters from the calcaneo bone. Mean of 3 measures was taken.

  6 month

Secondary Outcomes (16)

• Pain Assessment in the Affected Heel, by Visual Analog Scale.

  1 day.

• Pain Assessment in the Affected Heel, by Visual Analog Scale.

  1 month

• Pain Assessment in the Affected Heel, by Visual Analog Scale.

  3 month

• Pain Assessment in the Affected Heel, by Visual Analog Scale.

  6 month

• Pain Assessment in the Affected Heel After Long Periods of Rest, by Visual Analog Scale.

  1 day

Study Arms (2)

Physical therapy modalities

EXPERIMENTAL

Manual therapy techniques aimed to relaxed gastrocnemius and soleus muscles tone, movilizations, stretching and home exercises.

Other: Physical therapy modalities

Invasive Physical therapy modalities

EXPERIMENTAL

Manual therapy techniques aimed to relaxed gastrocnemius and soleus muscles tone, movilizations, stretching and home exercises. Previously, DN will be applied in gastrocnemius and soleus muscles.

Other: Physical therapy modalities; Device: Invasive Physical therapy modalities

Interventions

Physical therapy modalities OTHER

Massage, movilization of ankle dorsiflexion and improve flexibility with stretching of calf muscles.

Invasive Physical therapy modalities; Physical therapy modalities

Invasive Physical therapy modalities DEVICE

Dry needling added to massage, movilization of ankle dorsiflexion and improve flexibility with stretching of calf muscles.

Invasive Physical therapy modalities

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Ultrasonographic study in which a proximal thickened affected plantar fascia is observed -greater than or equal to 4 mm.
• Pain fell to the first steps in the morning.
• Pain with palpation at the insertion of the medial calcaneal tubercle, above 5, in a 10-point VAS.
• Pathology time evolution of greater than or equal to 4 weeks.
• Age of patients over 18 years.
• Acceptance by the patient to participate in the study, having signed the informed consent.

You may not qualify if:

• Presence of neoplastic disease.
• Presence of neurological, sensory, orthopedic and / or surgical alterations.
• The patient is already doing treatment of physical medicine and rehabilitation.
• Be subjected to antiplatelet drug therapy.
• Fear of needles (needle phobia).
• Difficulty for the patient to understand the instructions to be followed during the study.

Sponsors & Collaborators

• Universidad Complutense de Madrid: lead

Study Sites (1)

Clínica Universitaria de Podología de la Universidad Complutense de Madrid

Madrid, 28040, Spain

Location

MeSH Terms

Conditions

Fasciitis, Plantar

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Fasciitis; Musculoskeletal Diseases; Foot Diseases

Intervention Hierarchy (Ancestors)

Therapeutics; Rehabilitation

Results Point of Contact

• Title: Miguel Suárez Varela
• Organization: Universidad Complutense de Madrid

misuarezvarela@gmail.com

+34913941518

Study Officials

• Suárez Miguel, Physician

  Principal Investigator

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Physiotherapy degree

Study Record Dates

• First Submitted: May 27, 2015
• First Posted: June 10, 2015
• Study Start: May 1, 2014
• Primary Completion: April 1, 2016
• Study Completion: May 1, 2016
• Last Updated: September 9, 2020
• Results First Posted: August 18, 2020

Record last verified: 2020-07

Locations

ES (1)